DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Epitope topography of agonist antibodies to the checkpoint inhibitory receptor BTLA

Journal Article · · Structure
 [1];  [2];  [3];  [1];  [3];  [3];  [3];  [3];  [1];  [3];  [1];  [4];  [4];  [1];  [3]; ORCiD logo [1];  [3]
  1. Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA (United States)
  2. Eli Lilly and Company, San Diego, CA (United States); Discovery Biology, San Diego, CA (United States)
  3. Eli Lilly and Company, San Diego, CA (United States)
  4. Eli Lilly and Company, Indianapolis, IN (United States)

B and T lymphocyte attenuator (BTLA) is an attractive target for a new class of therapeutics that attempt to rebalance the immune system by agonizing checkpoint inhibitory receptors (CIRs). Herpesvirus entry mediator (HVEM) binds BTLA in both trans- and cis-orientations. We report here the development and structural characterization of three humanized BTLA agonist antibodies, 22B3, 25F7, and 23C8. We determined the crystal structures of the antibody-BTLA complexes, showing that these antibodies bind distinct and non-overlapping epitopes of BTLA. While all three antibodies activate BTLA, 22B3 mimics HVEM binding to BTLA and shows the strongest agonistic activity in functional cell assays and in an imiquimod-induced mouse model of psoriasis. 22B3 is also capable of modulating HVEM signaling through the BTLA-HVEM cis-interaction. The data obtained from crystal structures, biochemical assays, and functional studies provide a mechanistic model of HVEM and BTLA organization on the cell surface and informed the discovery of a highly active BTLA agonist.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF)
Grant/Contract Number:
AC02-05CH11231; AC02-06CH11357
OSTI ID:
2423419
Journal Information:
Structure, Journal Name: Structure Journal Issue: 8 Vol. 31; ISSN 0969-2126
Publisher:
ElsevierCopyright Statement
Country of Publication:
United States
Language:
English

References (33)

Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor Family journal November 1996
LIGHT, a New Member of the TNF Superfamily, and Lymphotoxin α Are Ligands for Herpesvirus Entry Mediator journal January 1998
Btla signaling in conventional and regulatory lymphocytes coordinately tempers humoral immunity in the intestinal mucosa journal March 2022
The Inhibitory Receptor BTLA Controls γδ T Cell Homeostasis and Inflammatory Responses journal December 2013
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity journal May 2016
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses journal May 2016
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family journal May 2016
Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1 journal March 2016
The Original Michaelis Constant: Translation of the 1913 Michaelis–Menten Paper journal October 2011
B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator journal November 2004
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator journal January 2008
A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors (Short Communication) journal January 1974
TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF- B pathway by TRAF-binding TNFRs journal February 2005
From The Cover: Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway journal August 2005
Unconventional ligand activation of herpesvirus entry mediator signals cell survival journal March 2009
Herpesvirus Entry Mediator, a Member of the Tumor Necrosis Factor Receptor (TNFR) Family, Interacts with Members of the TNFR-associated Factor Family and Activates the Transcription Factors NF-κB and AP-1 journal May 1997
A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator journal October 2017
Attenuating Lymphocyte Activity: THE CRYSTAL STRUCTURE OF THE BTLA-HVEM COMPLEX journal September 2005
T follicular helper cells in germinal center B cell selection and lymphomagenesis journal May 2020
The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation journal May 2009
The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation: HVEM networks in disease journal October 2011
Combined Coinhibitory and Costimulatory Modulation with Anti-BTLA and CTLA4Ig Facilitates Tolerance in Murine Islet Allografts journal December 2007
Steric Hindrance Mutagenesis versus Alanine Scan in Mapping of Ligand Binding Sites in the Tachykinin NK1Receptor journal January 1998
Coinhibitory Pathways in Immunotherapy for Cancer journal May 2016
The b7 Family Revisited journal April 2005
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4 journal November 2019
Regulation of inflammation, autoimmunity, and infection immunity by HVEM-BTLA signaling journal November 2010
Not All Immune Checkpoints Are Created Equal journal August 2018
BTLA inhibition has a dominant role in the cis-complex of BTLA and HVEM journal August 2022
T Cell Intrinsic Heterodimeric Complexes between HVEM and BTLA Determine Receptivity to the Surrounding Microenvironment journal November 2009
Constitutive Expression of LIGHT on T Cells Leads to Lymphocyte Activation, Inflammation, and Tissue Destruction journal December 2001
Differential Effects of B and T Lymphocyte Attenuator and Programmed Death-1 on Acceptance of Partially versus Fully MHC-Mismatched Cardiac Allografts journal November 2005
B and T Lymphocyte Attenuator Regulates B Cell Receptor Signaling by Targeting Syk and BLNK journal February 2009